Abstract:
The present invention relates to a power and/or telecommunication cable comprising at least one conductive element surrounded by at least one insulating layer extending along the cable, the isolating layer being obtained from a composition containing the following compounds: a) an organic polymer; b) an inorganic compound containing a potassium oxide and/or one of the precursors thereof; c) a boron oxide and/or one of the precursors thereof; and d) calcium oxide CaO and/or one of the precursors thereof, characterized in that the amount of the compound d is at least 10 wt % of the total weight of the compounds b, c, and d in the composition.
Abstract:
A transmission method and device are provided for taking account of an echo. The method and the device adapt the send power mask to take account of an echo's power estimated on the basis of an echo function, the echo being due to the transmission by a transmission channel of a sequence sent by the sender device.
Abstract:
A packet network node and method of operating a packet network node are disclosed. Conventional packet network nodes react to congestion in the packet network by dropping packets in a manner which is perceived by users to be indiscriminate. In embodiments of the present invention, communication sources precede communications with a start packet which contains a communication identifier also carried within subsequent packets of the communication. The packet network node makes an entry in a vulnerable communications table (6.4) on receipt of such a start packet. After an amount of time, and often before the cessation of a communication, such entries are removed from the vulnerable communications table. On the onset of congestion, the packet network node disclosed herein deletes packets in communications identified in the vulnerable communications table. This provides a congestion alleviation method which is less annoying to users since communications that have been in existence for longer are less susceptible to component packets being deleted.
Abstract:
The present invention relates to derivatives of aroyl-O-piperidine structure of the general formula (I): in which R1, R2, R3 and R4 are as defined in the description. Application of the compounds of the formula (I) to the treatment of hyper-triglyceridaemia, hypercholesterolaemia and dyslipidaemia, and to the prevention or treatment of obesity.
Abstract:
A method of applying a patterned thin-film onto a substrate comprising the steps of plasma treating the substrate. Applying a liquid coating material, comprising one or more compounds selected from the group of organopolysiloxane polymers, organopolysiloxane oligomers, siloxane resins and polysilanes, onto the substrate surface, by a soft lithographic printing technique, preferably microcontact printing to form a patterned film thereon. Where required any residual liquid coating material may be removed from the substrate surface. The process does not require the liquid coating material undergo a curing step such as is required in Decal Transfer Microlithography techniques. Any suitable form of plasma treatment may be used to activate the substrate prior to printing.
Abstract translation:一种将图案化薄膜施加到基底上的方法,包括等离子体处理基底的步骤。 通过软平版印刷技术将包含一种或多种选自有机聚硅氧烷聚合物,有机聚硅氧烷低聚物,硅氧烷树脂和聚硅烷的化合物的液体涂料施用于基材表面上,优选微接触印刷以在其上形成图案化膜。 如果需要,可以从基材表面除去残留的液体涂料。 该方法不需要液体涂覆材料经历诸如Decal Transfer Microlithography技术中所需的固化步骤。 可以使用任何合适的等离子体处理形式来在印刷之前激活基板。
Abstract:
An amino-functional polysiloxane is prepared by reacting an aminosilane (A) which contains an aminoalkyl group and at least one alkoxy group bonded to Si with a carboxylic acid and a silanol-functional polysiloxane (B). The aminosilane (A) is partially converted into its carboxylate salt which acts as a catalyst for the siloxane condensation polymerization reaction between (A) and (B).
Abstract:
The present invention provides cationic dendrimers for delivering bioactive molecules, such as polynucleotide molecules, peptides and polypeptides and/or pharmaceutical agents, to a mammalian body. The dendrimers disclosed herein are suitable for targeting the delivery of the bioactive molecules to, for example, the liver, spleen, lung, kidney or heart.
Abstract:
A polymerization process comprising mixing siloxane polymers with organosilicon compounds having at least one silicon-bonded group RN, which is a substituent comprising at least one amine group, and with a phosphazene base catalyst and allowing the siloxanes and organosilicon compounds to polymerize to form amino-functional polyorganosiloxane polymers is claimed. Preferably the phosphazene base is selected from the following formulae: ((R12N)3P═N—)x(R12N)3−xP═NR2; {((R12N)3P═N—)x(R12N)3−xP—N(H)R2}+{A−} {((R12N)3P═N—)y(R12N)4−yP}+{A}− or {(R12N)3P═N—(P(NR12)2═N)n—P+(NR12)3}{A−} in which R1 is hydrogen or an optionally substituted hydrocarbon group, or in which two R1 groups bonded to the same N atom may be linked to complete a heterocyclic ring, R2 is hydrogen or an optionally substituted hydrocarbon group, x is 1, 2 or 3; y is 1, 2, 3 or 4, n is an integer with a value of from 1 to 10 and A is an anion.
Abstract:
A polymerization process comprising mixing siloxanes having silicon-bonded groups R′ with ionic phosphazene base catalysts and allowing condensation via reaction of Si—R′ groups with the formation of a Si—O—Si linkage, R′ denoting a hydroxyl group or a hydrocarbonoxy group having up to 8 carbon atoms is claimed. The catalysts may be of the general formulae: {((R12N)3P═N—)x(R12N)3−xP—N(H)R2}+{A−} or {((R12N)3P═N—)y(R12N)4−yP}+{A}− in which R1 is hydrogen or an optionally substituted hydrocarbon group or in which two R1 groups bonded to the same N atom may be linked to complete a heterocyclic ring, R2 is hydrogen or an optionally substituted hydrocarbon group, x is 1, 2 or 3, y is 1, 2, 3 or 4 and A is an anion. Also claimed is a process which comprises mixing siloxanes having silicon-bonded groups R′ and cyclic or linear siloxanes having no silicon-bonded groups R′ with ionic phosphazene base catalysts and allowing the siloxane having silicon-bonded groups R′ to condense and the cyclic and linear siloxanes having no silicon-bonded R′ groups to polymerize by equilibration.